Discover 1,705 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,705
Active & Responsive
Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
Location: Flint MI, Corunna MI, Midland MI, Grand Rapids MI,
Sponsor: Michigan State University
Sex: Female
Age: 18+
Code: NCT07213284
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Detroit MI, Dearborn MI, Grosse Pointe Woods MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Detroit MI, Grosse Pointe Woods MI, Warren MI,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase3, Recruiting
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
for
Post Traumatic Stress Disorder
Location: Detroit MI, Ann Arbor MI, Fremont OH, East Lansing MI,
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT05751473
Recruiting
A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations
for
Advanced Solid Tumors With MAPK Pathway Mutations
Location: Detroit MI, Nashville TN, Houston TX
Sponsor: D3 Bio (Wuxi) Co., Ltd
Sex: All
Age: 18+
Code: NCT05886920
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Impact of the Parenting Young Children Check-up
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumors
Location: Detroit MI, Pittsburgh PA, Toronto, Cincinnati OH,
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
for
Solid Tumor
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Fairfax VA,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06874335
Phase1, Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: Detroit MI, Toronto, Pittsburgh PA, Chicago IL,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 16+
Code: NCT06617325
Phase3, Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Detroit MI, Chicago IL, Milwaukee WI, Nicholasville KY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase2, Recruiting
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Detroit MI, East Lansing MI, Cincinnati OH,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07039916
Phase3, Recruiting
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Detroit MI, St Louis MO, Raleigh NC, Tampa FL,
Sponsor: MOMA Therapeutics
Sex: All
Age: 18+
Code: NCT06974110
Phase1, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations